Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cross-Talk Between Histone Methyltransferases and Demethylases Regulate REST Transcription During Neurogenesis. | Front Oncol | 2022 | 35600406 | PubTator, text mining | PubMed |
| Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insights. | Cell Rep Med | 2022 | 35584622 | PubTator, text mining | PubMed |
| An Insight into the Medicinal Chemistry Perspective of Macrocyclic Derivatives with Antitumor Activity: A Systematic Review. | Molecules | 2022 | 35566196 | PubTator, text mining | PubMed |
| A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients. | Cancers (Basel) | 2022 | 35565241 | PubTator, text mining | PubMed |
| DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives. | Cells | 2022 | 35563769 | PubTator, text mining | PubMed |
| Moving Average-Based Multitasking In Silico Classification Modeling: Where Do We Stand and What Is Next? | Int J Mol Sci | 2022 | 35563327 | PubTator, text mining | PubMed |
| Histone Acetylation and Modifiers in Renal Fibrosis. | Front Pharmacol | 2022 | 35559244 | PubTator, text mining | PubMed |
| Overcoming Cancer Drug Resistance Utilizing PROTAC Technology. | Front Cell Dev Biol | 2022 | 35547806 | PubTator, text mining | PubMed |
| The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells. | Sci Rep | 2022 | 35546353 | PubTator, text mining | PubMed |
| Induction of the BRAFV600E Mutation in Thyroid Cells Leads to Frequent Hypermethylation. | Clin Exp Otorhinolaryngol | 2022 | 35538718 | PubTator, text mining | PubMed |
| The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. | Cell Mol Life Sci | 2022 | 35532818 | PubTator, text mining | PubMed |
| A Tau Pathogenesis-Based Network Pharmacology Approach for Exploring the Protections of Chuanxiong Rhizoma in Alzheimer's Disease. | Front Pharmacol | 2022 | 35529440 | PubTator, text mining | PubMed |
| Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects. | Front Immunol | 2022 | 35514959 | PubTator, text mining | PubMed |
| The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress. | Elife | 2022 | 35503721 | PubTator, text mining | PubMed |
| Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury. | Neurotherapeutics | 2022 | 35501470 | PubTator, text mining | PubMed |
| Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. | PLoS One | 2022 | 35486664 | PubTator, text mining | PubMed |
| Exploring epigenetic reprogramming during central nervous system infection. | Immunol Rev | 2022 | 35481573 | PubTator, text mining | PubMed |
| Designing Soluble PROTACs: Strategies and Preliminary Guidelines. | J Med Chem | 2022 | 35469399 | PubTator, text mining | PubMed |
| Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants. | Genome Med | 2022 | 35468861 | PubTator, text mining | PubMed |
| R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition. | J Cancer Res Clin Oncol | 2022 | 35467128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=27